GÜZEL, E. Et Al. 2024. Use of CRP/lymphocyte ratio as a predictor of treatment selection and mortality in COVID-19 patients in the intensive care unit. International Journal of Immunopathology and Pharmacology , vol.38 .

GÜZEL, E., METE, B., BAYDAR TOPRAK, O., Ates Ayhan, N., Firat, A., Bulut, Y., ... Bayrakci, S.(2024). Use of CRP/lymphocyte ratio as a predictor of treatment selection and mortality in COVID-19 patients in the intensive care unit. International Journal of Immunopathology and Pharmacology , vol.38.

GÜZEL, EFRAİM Et Al. "Use of CRP/lymphocyte ratio as a predictor of treatment selection and mortality in COVID-19 patients in the intensive care unit," International Journal of Immunopathology and Pharmacology , vol.38, 2024

GÜZEL, EFRAİM Et Al. "Use of CRP/lymphocyte ratio as a predictor of treatment selection and mortality in COVID-19 patients in the intensive care unit." International Journal of Immunopathology and Pharmacology , vol.38, 2024

GÜZEL, E. Et Al. (2024) . "Use of CRP/lymphocyte ratio as a predictor of treatment selection and mortality in COVID-19 patients in the intensive care unit." International Journal of Immunopathology and Pharmacology , vol.38.

@article{article, author={EFRAİM GÜZEL Et Al. }, title={Use of CRP/lymphocyte ratio as a predictor of treatment selection and mortality in COVID-19 patients in the intensive care unit}, journal={International Journal of Immunopathology and Pharmacology}, year=2024}